Vitruvias Therapeutics Thyroid Drug Recall Elevated to FDA’s Highest-Risk Class I Level -What It Means

Vitruvias Therapeutics, based in Auburn, Alabama, has issued a nationwide consumer-level recall of one lot of its Thyroid Tablets, USP 30 mg, following FDA confirmation that the medication could be superpotent. The post Vitruvias Therapeutics Thyroid Drug Recall Elevated to FDA’s Highest-Risk Class I Level -What It Means appeared first on The Sunday Guardian .